What was the purpose of this study?
The main questions the researchers wanted to answer in this study were:

- After 16 weeks, did the participants feel that dapagliflozin helped their overall heart failure symptoms?
- After 16 weeks, did the participants feel that dapagliflozin helped their physical symptoms caused by heart failure?
- After 16 weeks, could the participants who took dapagliflozin walk farther in 6 minutes?
- What medical problems did the participants have during the study?

The answers to these questions are important to know to understand how dapagliflozin can help improve the health of people with HFpEF.